THE MBL77 DIARIES

Not all patients with CLL call for therapy. Even with all the latest advances, the iwCLL continue to suggests watchful observation for individuals with asymptomatic ailment.86 This suggestion relies on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Du